Dr. Jenna Kelly, short biography
Dr. Jenna Kelly studied Medical Sciences at the Schulich School of Medicine and Dentistry, London, Canada and completed a PhD in Microbiology and Immunology at Western University, London with a thesis titled “Evolutionary and in silico analysis of the antiviral TRIM22 gene. Following this, Jenna was a research fellow at the Viral Special Pathogens Branch of the Centers for Disease Control and Prevention (CDC) in Atlanta, with funding from an APHL Bioinformatics in Public Health fellowship. Since 2018, Jenna has been a Postdoc at the Institute for Virology and Immunology (IVI) at the Vetsuisse, University of Bern in the research group of Prof. Dr. Volker Thiel, where her research has focused on the bioinformatic analysis of viral sequences, including SARS-CoV-2. Jenna was awarded an MCID Career Development Grant as part of a Multi-Applicant proposal titled “An integrative One Health network to monitor and characterize influenza A viruses circulating in the human and pig population”, which began in 2022.
Jenna has contributed to a number of publications, including the following:
Kelly, J.N., et al. (2022). Comprehensive single cell analysis of pandemic influenza A virus infection in the human airways uncovers cell-type specific host transcriptional signatures relevant for disease progression and pathogenesis. Frontiers in Immunology, 13:978824
Tuba Barut, G., Halwe, N.J., Taddeo, A., Kelly, J.N., et al. (2022). The spike gene is a major determinant for the SARS-CoV-2 Omicron-BA.1 phenotype. Nature Communications 7; 13(1):5929
V'kovski P., Gultom M., Kelly J.N., et al. (2021). Disparate temperature-dependent virus-host dynamics for SARS-CoV-2 and SARS-CoV in the human respiratory epithelium. PLoS Biology 19(3):e3001158.
Kratzel, A., Kelly, J.N, et al. (2021). A genome-wide CRISPR screen identifies interactors of the autophagy pathway as conserved coronavirus targets. PLoS Biology 19(12):e3001490.
|
